Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-22 11:12 am Purchase |
2021-01-12 | 13G | IDEAYA Biosciences, Inc. IDYA |
RTW Investments, LP | 2,096,843 7.210% |
2,096,843 (New Position) |
Filing History |
| 2021-01-19 1:24 pm Purchase |
2021-01-07 | 13D | DermTech, Inc. DMTKQ |
RTW Investments, LP | 3,118,666 13.090% |
460,039 (+17.30%) |
Filing History |
| 2021-01-08 3:30 pm Purchase |
2020-12-10 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 17,530,044 29.300% |
247,720 (+1.43%) |
Filing History |
| 2020-12-03 09:29 am Purchase |
2020-11-06 | 13G | Cogent Biosciences, Inc. COGT |
RTW Investments, LP | 1,258,750 9.990% |
1,258,750 (New Position) |
Filing History |
| 2020-11-16 11:02 am Purchase |
2020-11-05 | 13G | Aptevo Therapeutics Inc. APVO |
RTW Investments, LP | 178 8.970% |
178 (New Position) |
Filing History |
| 2020-11-13 09:57 am Purchase |
2020-11-03 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 2,071,409 7.550% |
2,071,409 (New Position) |
Filing History |
| 2020-10-26 2:16 pm Purchase |
2020-10-16 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,463,601 12.790% |
2,463,601 (New Position) |
Filing History |
| 2020-09-28 3:59 pm Purchase |
2020-09-18 | 13G | Athira Pharma, Inc. ATHA |
RTW Investments, LP | 2,668,913 8.660% |
2,668,913 (New Position) |
Filing History |
| 2020-06-29 2:51 pm Purchase |
2020-06-19 | 13G | IVERIC bio, Inc. ISEE |
RTW Investments, LP | 6,121,882 8.070% |
6,121,882 (New Position) |
Filing History |
| 2020-06-22 09:14 am Purchase |
2020-06-11 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 3,995,000 11.300% |
3,995,000 (New Position) |
Filing History |
| 2020-06-19 10:36 am Purchase |
2020-06-11 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 1,885,000 9.950% |
1,885,000 (New Position) |
Filing History |
| 2020-06-11 08:54 am Purchase |
2020-06-01 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 1,255,857 8.260% |
1,255,857 (New Position) |
Filing History |
| 2020-05-22 12:37 pm Purchase |
2020-05-15 | 13G | Oyster Point Pharma, Inc. OYST |
RTW Investments, LP | 1,914,606 7.620% |
1,914,606 (New Position) |
Filing History |